May 2020
AccelevirDx announces award of an NIH contract to expand subtype coverage of test for HIV persistence

April 2020
AccelevirDx announces award of a multi-year NIH Cooperative Agreement to establish a centralized testing resource for HIV persistence

March 2020
AccelevirDx is proud to announce our participation in six accepted abstracts at CROI 2020

[…]

April 2020

Acquired ODD status for liver cancer and intrahepatic bile duct cancer and License-In for additional Indications.

Dietary supplement sales contract with KoDiscovery and Sales started in March.

December 2019

Seminars about Anti- Bacteria Treatment using 3BP with the University of Wroclaw, Poland.

[…]

Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says.

[…]